Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation

BACKGROUND: Bradykinin (BK) induces angiogenesis by promoting vessel permeability, growth and remodeling. This study aimed to demonstrate that the B2R antagonist, fasitibant, inhibits the BK pro-angiogenic effects. METHODOLOGY: We assesed the ability of fasibitant to antagonize the BK stimulation of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Terzuoli, Erika, Meini, Stefania, Cucchi, Paola, Catalani, Claudio, Cialdai, Cecilia, Maggi, Carlo Alberto, Giachetti, Antonio, Ziche, Marina, Donnini, Sandra
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3879294/
https://ncbi.nlm.nih.gov/pubmed/24392129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0084358
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires